# EDGAR Filing Document

**Accession Number:** 0001787740
**File Stem:** 0000000000-25-006369
**Filing Date:** 2025-6
**Character Count:** 4277
**Document Hash:** c79581b51a6906b80b622972db528956
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000000000-25-006369.hdr.sgml**: 20250918

**ACCESSION NUMBER**: 0000000000-25-006369

**CONFORMED SUBMISSION TYPE**: UPLOAD

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250617

**FILED FOR**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Tivic Health Systems, Inc.
- **CENTRAL INDEX KEY:** 0001787740
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 814016391
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** UPLOAD
- **SEC FILE NUMBER:** 377-08017

**BUSINESS ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
- **BUSINESS PHONE:** (888)276-6888

**MAIL ADDRESS:**
- **STREET 1:** 47685 LAKEVIEW BLVD
- **CITY:** FREMONT
- **STATE:** CA
- **ZIP:** 94538
**PUBLIC REFERENCE ACCESSION NUMBER**: 0001683168-25-003732

## Text-Extract

```

                                                            June 17, 2025

Jennifer Ernst
Chief Executive Officer
Tivic Health Systems, Inc.
47685 Lakeview Blvd.
Fremont, California 94538

        Re: Tivic Health Systems, Inc.
            Registration Statement on Form S-1
            Filed June 6, 2025
            File No. 333-287853
Dear Jennifer Ernst:

     We have reviewed your amended registration statement and have the
following
comment.

        Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

       After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our May 21, 2025
letter.

Registration Statement on Form S-1 filed June 6, 2025
Plan of Distribution, page 16

1.     We note your response to previous comment 1. Section 2.3(b)(xiv) of the
Securities
       Purchase Agreement entered into with the Selling Stockholder on April
29, 2025
       appears to provide that the Selling Stockholder's obligation to purchase
each tranche
       of Preferred Shares is subject to the closing price of the Company's
common stock
       being equal to or greater than the Floor Price of $1.294 per share for a
period
       proceeding each Tranche Closing Date. Please clarify whether the Selling
Stockholder
       is irrevocably bound to purchase a given tranche of Preferred Stock if
the Company's
       common stock is trading below the Floor Price. As noted in CD&I 139.11,
"closing
       conditions in capital formation transactions relating to the market
price of the
       company   s securities . . . are unacceptable conditions" when a company
is attempting
 June 17, 2025
Page 2

       to register the resale of common stock underlying convertible securities
prior to the
       issuance of the convertible securities. Additionally, CD&I 139.11
provides that in
       such a scenario, "[t]he closing of the private placement of the unissued
securities must
       occur within a short time after the effectiveness of the resale
registration statement." It
       appears that the six tranche closing dates will be staggered with the
final Tranche
       Closing scheduled to occur within 90 trading days after the
effectiveness of the
       registration statement. Please provide us with your analysis of whether
90 trading
       days constitutes a "short time" in this context.
       Please contact Conlon Danberg at 202-551-4466 or Jane Park at
202-551-7439 with
any questions.

                                                              Sincerely,

                                                              Division of
Corporation Finance
                                                              Office of
Industrial Applications and
                                                              Services
cc:   Christopher L. Tinen, Esq.

```

### Attached PDF Documents

**Attachment 1:** `filename1`

_No text found in this document._